These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16291600)

  • 21. Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: A randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial.
    Leung AT; Malmstrom K; Gallacher AE; Sarembock B; Poor G; Beaulieu A; Castro R; Sanchez M; Detora LM; Ng J
    Curr Med Res Opin; 2002; 18(2):49-58. PubMed ID: 12017209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.
    Bingham CO; Sebba AI; Rubin BR; Ruoff GE; Kremer J; Bird S; Smugar SS; Fitzgerald BJ; O'Brien K; Tershakovec AM
    Rheumatology (Oxford); 2007 Mar; 46(3):496-507. PubMed ID: 16936327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pain management after elective hallux valgus surgery: a prospective randomized double-blind study comparing etoricoxib and tramadol.
    Brattwall M; Turan I; Jakobsson J
    Anesth Analg; 2010 Aug; 111(2):544-9. PubMed ID: 20584877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etoricoxib provides analgesic efficacy to patients after knee or hip replacement surgery: a randomized, double-blind, placebo-controlled study.
    Rasmussen GL; Malmstrom K; Bourne MH; Jove M; Rhondeau SM; Kotey P; Ang J; Aversano M; Reicin AS;
    Anesth Analg; 2005 Oct; 101(4):1104-1111. PubMed ID: 16192529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the comparative efficacy of etoricoxib and ibuprofen for treatment of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial.
    Wiesenhutter CW; Boice JA; Ko A; Sheldon EA; Murphy FT; Wittmer BA; Aversano ML; Reicin AS;
    Mayo Clin Proc; 2005 Apr; 80(4):470-9. PubMed ID: 15819283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complementary studies of the gastrointestinal safety of the cyclo-oxygenase-2-selective inhibitor etoricoxib.
    Hunt RH; Harper S; Callegari P; Yu C; Quan H; Evans J; James C; Bowen B; Rashid F
    Aliment Pharmacol Ther; 2003 Jan; 17(2):201-10. PubMed ID: 12534404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies.
    Birbara C; Ruoff G; Sheldon E; Valenzuela C; Rodgers A; Petruschke RA; Chang DJ; Tershakovec AM
    Curr Med Res Opin; 2006 Jan; 22(1):199-210. PubMed ID: 16393445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs in controlled clinical trials.
    Curtis SP; Ng J; Yu Q; Shingo S; Bergman G; McCormick CL; Reicin AS
    Clin Ther; 2004 Jan; 26(1):70-83. PubMed ID: 14996519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis.
    Nickel JC; Pontari M; Moon T; Gittelman M; Malek G; Farrington J; Pearson J; Krupa D; Bach M; Drisko J;
    J Urol; 2003 Apr; 169(4):1401-5. PubMed ID: 12629372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of etoricoxib compared with NSAIDs in acute gout: a systematic review and a meta-analysis.
    Zhang S; Zhang Y; Liu P; Zhang W; Ma JL; Wang J
    Clin Rheumatol; 2016 Jan; 35(1):151-8. PubMed ID: 26099603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there any analgesic benefit from preoperative vs. postoperative administration of etoricoxib in total knee arthroplasty under spinal anaesthesia?: A randomised double-blind placebo-controlled trial.
    Munteanu AM; Cionac Florescu S; Anastase DM; Stoica CI
    Eur J Anaesthesiol; 2016 Nov; 33(11):840-845. PubMed ID: 27454662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis.
    Schumacher HR; Boice JA; Daikh DI; Mukhopadhyay S; Malmstrom K; Ng J; Tate GA; Molina J
    BMJ; 2002 Jun; 324(7352):1488-92. PubMed ID: 12077033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analgesic efficacy of etoricoxib in primary dysmenorrhea: results of a randomized, controlled trial.
    Malmstrom K; Kotey P; Cichanowitz N; Daniels S; Desjardins PJ
    Gynecol Obstet Invest; 2003; 56(2):65-9. PubMed ID: 12900528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etoricoxib.
    Cochrane DJ; Jarvis B; Keating GM
    Drugs; 2002; 62(18):2637-51; discussion 2652-3. PubMed ID: 12466002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal numbers-needed-to-treat (NNT) for achieving various levels of analgesic response and improvement with etoricoxib, naproxen, and placebo in ankylosing spondylitis.
    Peloso PM; Gammaitoni A; Smugar SS; Wang H; Moore AR
    BMC Musculoskelet Disord; 2011 Jul; 12():165. PubMed ID: 21767407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rofecoxib as adjunctive therapy for haemophilic arthropathy.
    Rattray B; Nugent DJ; Young G
    Haemophilia; 2005 May; 11(3):240-4. PubMed ID: 15876269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of etoricoxib and celecoxib for pain prevention after periodontal surgery: a double-masked, parallel-group, placebo-controlled, randomized clinical trial.
    Steffens JP; Santos FA; Pilatti GL
    J Periodontol; 2011 Sep; 82(9):1238-44. PubMed ID: 21235334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A placebo and active comparator-controlled trial of rofecoxib for the treatment of rheumatoid arthritis.
    Geusens PP; Truitt K; Sfikakis P; Zhao PL; DeTora L; Shingo S; Lau CS; Kalla A; Tate G
    Scand J Rheumatol; 2002; 31(4):230-8. PubMed ID: 12369656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial.
    Rubin BR; Burton R; Navarra S; Antigua J; Londoño J; Pryhuber KG; Lund M; Chen E; Najarian DK; Petruschke RA; Ozturk ZE; Geba GP
    Arthritis Rheum; 2004 Feb; 50(2):598-606. PubMed ID: 14872504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases.
    El Miedany Y; Youssef S; Ahmed I; El Gaafary M
    Am J Gastroenterol; 2006 Feb; 101(2):311-7. PubMed ID: 16454836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.